Effect of Atorvastatin to decrease intensity of clinical manifestations in patient with COVID19

Phase 3

Recruiting

• Conditions: Coronavirus Disease 2019 (COVID19).; COVID-19, virus identified; U07.1

• Registration Number: IRCT20201028049175N3
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients with 18-75 years old
Patients with positive PCR test for COVID19 who ara referred to Amiralmomenin and Khansari hospitals of Arak city
Patients who have informed consent for entrance into the study.

Exclusion Criteria

Pregnancy and lactation

Study & Design

• Study Type: interventional
• Study Design: Not specified